Drug intelligence / Profile preview

belladonna + morphine

Development stage
Phase 4
Modality
Small Molecules
Administration
Oral, Rectal
01

Overview

Belladonna + morphine is a combination pharmaceutical product comprising belladonna alkaloids and the opioid analgesic morphine. This medication is primarily utilized for its synergistic antispasmodic and analgesic properties in managing severe pain associated with smooth muscle spasms. Morphine, a potent mu-opioid receptor agonist, acts centrally to elevate the pain threshold and alter the perception of painful stimuli. The belladonna alkaloids, which include atropine, hyoscyamine, and scopolamine, function as competitive muscarinic acetylcholine receptor antagonists. By inhibiting parasympathetic stimulation, these alkaloids induce smooth muscle relaxation and reduce secretions, which is particularly effective in treating conditions such as ureteral colic, gastrointestinal spasms, and post-surgical bladder spasms. Historically, this combination has been available as oral mixtures for gastrointestinal distress or as rectal formulations for genitourinary conditions.

Other names
Belladonna and Morphine MixtureMorphine and Belladonna MixtureMorphine and BelladonnaBelladonna and Morphine
02

Targets

DOR (Opioid Receptor Delta 1)KOR (Kappa opioid receptor)MOR (Mu opioid receptor)mAChR (Muscarinic acetylcholine receptors)

Beyond the preview

Go deeper on belladonna + morphine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on belladonna + morphine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call